Capital Fund Management (CFM)’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.49M | Buy |
371,607
+235,353
| +173% | +$2.21M | 0.01% | 497 |
|
|
2025
Q1 | $969K | Buy |
+136,254
| New | +$969K | ﹤0.01% | 661 |
|
|
2024
Q4 | – | Sell |
-18,705
| Closed | -$384K | – | 1020 |
|
|
2024
Q3 | $384K | Buy |
+18,705
| New | +$384K | ﹤0.01% | 660 |
|
|
2024
Q2 | – | Sell |
-92,578
| Closed | -$2.55M | – | 948 |
|
|
2024
Q1 | $2.55M | Buy |
+92,578
| New | +$2.55M | 0.01% | 434 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 969 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 877 |
|
|
2023
Q2 | – | Sell |
-107,656
| Closed | -$4.01M | – | 849 |
|
|
2023
Q1 | $4.01M | Sell |
107,656
-2,233
| -2% | -$83.2K | 0.02% | 256 |
|
|
2022
Q4 | $3.83M | Buy |
+109,889
| New | +$3.83M | 0.03% | 256 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 792 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 778 |
|